R ecently, the House of Representatives was presented a bill regarding reform of the US health care system framework. The House is currently in recess, and senators and representatives are finally communicating with the public about this issue. I am not in disagreement that changes could be made within the current health care structure, including insurance and tort reform. However, an inevitable single-payor, government-run system should never be considered. Increased ancillary care responsibilities within the system, including those that pharmacy could and should manage, are of important but secondary concern. The pharmacy profession's penultimate consideration before attempting to obtain a "seat at the table" should be ensuring that any plan will pay for itself without a reduction in quality or rationing of care.
Because of the devastating effects health care costs have had on the economy, the current administration promised more coverage at less cost with the new plan. However, once the bill was evaluated by the Congressional Budget Office, it was found that the plan would increase costs by more than $1 trillion dollars. President Obama then stated that he would not sign the bill unless it was revenue neutral. If the previously stated urgency was based on the high cost of care, what good could come of restructuring the health care system for revenue neutrality? Citizens recognize that this would lead to additional tax increases when the economy is already in a deep recession. These tax increases would hit the investor class and small businesses the hardest.
I am speechless about many of the points in the House bill; following are a few: • The government would have real-time access to individuals' finances and bank accounts for electronic transfer of funds. • It would be required that employers enroll employees in the public option plan. • Individuals who do not have acceptable health care, based on government standards, would be taxed 2.5% of their income. • The government would restrict enrollment of people with special needs. • The government would mandate advanced care planning consults, which may include orders for end of life. It is my hope that by the time of this article's publication, this bill will have been amended or negotiated, but understanding how initiatives could be proposed that seemingly point to rationing of care and further government intrusion into our lives is difficult. Furthermore, I find it hard to believe that throughout this debate not a word has addressed the most egregious examples of waste in the current system: the cost of the malpractice system, the cost of malpractice insurance that is passed along to patients, and judicial awards that are passed along to the insurance companies that increase premiums-not to mention the monies going to lawyers. Another source of waste is the cost associated with the practice of defensive medicine to protect physicians from lawsuits. Tort re form is necessary, but there is no mention of it in the current House bill.
I recognize that it is early in the debate and that little is known about the key components of the bill: what is covered (and for how long) and what is not. At publicaton, if this issue has been tabled or postponed, then at least more insight will be provided into the medical ethics of this administration. If Congress takes the nuclear option and that option is forced on society with little negotiation, pharmacy practitioners must do all possible to ensure that physicians, pharmacists, and patients remain at the center of the drug therapy management decision process. Yet this is only possible when patients, rather than the government, control their health care dollars.
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